Primers, primer combinations, kits and their applications

A kit and primer set technology, applied in the direction of protozoa, biochemical equipment and methods, microbial measurement/testing, etc., can solve problems affecting the sensitivity and specificity of amplification

Active Publication Date: 2019-08-06
NANJING SIMCERE MEDICAL LAB CO LTD +3
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in actual operation, it is found that due to factors such as interference between multiple primers, the non-specific amplification generated seriously affects the sensitivity and specificity of amplification.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primers, primer combinations, kits and their applications
  • Primers, primer combinations, kits and their applications
  • Primers, primer combinations, kits and their applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 115

[0181] Example 1 Construction of 15 mutant plasmids

[0182] (1) Amplify the NPM1 fragment containing the insertion mutation: in such as Figure 5 Design primers at both ends of the shown insert fragments, design bidirectional primers containing deletion mutation fragments at the mutation site, and use bridge PCR to construct NPM1 fragments containing insertion mutations;

[0183] (2) Ligation and transformation reactions: use a commercial kit to connect the NPM1 mutant fragment and the PMD19-T vector and transform it into DH5α Escherichia coli;

[0184] (3) Pick positive clones and preserve species: Spread Escherichia coli on LB agarose medium containing ampicillin and culture overnight at 37°C, pick a single colony, and use the two-terminal specificity markers in the insert to select a part of them. Amplify with primers, and the cloned colonies that can amplify the target band size are sent to be sequenced and confirmed as positive, and then stored with 25% glycerol at -20°...

Embodiment 2

[0187] Embodiment 2 utilizes each primer real-time PCR to detect the specificity of each mutant separately

[0188] grouping:

[0189] Experimental group: 15 mutated plasmids constructed in Example 1;

[0190] The negative control is wild-type NPM1; the blank control is water.

[0191] (1) Plasmid dilution: Dilute wild-type (WT), typeA, typeB, typeD, typeDD1, typeE mutant NPM1 plasmids to 2.7x10 5 copies / uL.

[0192](2) Real-time PCR reaction: Prepare reaction system in PCR tube: 10 μl of commercial Taq enzyme PCR Mix (2x), 0.8 μl of primer X, 10.8 μl of primer, 10.5 μl of probe, mutant type diluted in (1) Plasmid / (1) diluted wild-type plasmid / water 1μl, cDNA extracted from HL60 cell line 1uL, make up to 20μl with sterilized deionized water;

[0193] Wherein, primer X is the corresponding primer (SEQ ID No.2~6) when detecting different mutant plasmids, the concentration is 4~8pmol / μl, and the concentration of primer 1 (SEQ ID No.7) is 4~8pmol / μl, The concentration of prob...

Embodiment 3

[0204] Embodiment 3 utilizes mixed primer to carry out real-time PCR detection to fifteen kinds of mutants

[0205] grouping:

[0206] Experimental group: 15 mutated plasmids constructed in Example 1;

[0207] The negative control is wild-type NPM1; the blank control is water.

[0208] (1) Plasmid dilution: Dilute wild-type (WT), typeA, typeB, typeD, typeDD1, typeE, typeF, typeG, typeH, typeI, typeJ, typeK, typeL, typeM, typeN, typeO mutant NPM1 plasmids to 5 Gradients: 2.7x10 5 copies / uL, 2.7x10 4 copies / uL, 2.7x10 3 copies / uL, 2.7x10 2 copies / uL, 2.7x10 2 copies / uL, 2.7x10 1 copies / uL.

[0209] (2) Real-time PCR reaction: prepare reaction system in PCR tube: commercial Taq enzyme PCR Mix (2x) 10 μl, primer mixture 1.6 μl, probe 10.5 μl, template cDNA / negative control reagent / positive control reagent 2 μl, Make up to 20μl with sterilized deionized water;

[0210] The above-mentioned primer mixture contains the above-mentioned 6 specific primers (SEQ ID No.7, SEQ ID ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of biotechnology, in particular to a primer, a primer combination, a kit and application of the primer. At least 17 NPM1 mutants are specifically detected on the cDNA level through the digital microdroplet PCR of multiple mixing primers once. The primer mainly aims at detecting the minimal residual disease after the AML treatment, and can also be used to identifythe NPM1 mutation of a first-visit patient.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to primers, primer combinations, kits and applications thereof. Background technique [0002] Minimal residual disease (MRD) refers to submicroscopic lesions that still exist in the body without clinical symptoms after hematological tumors have achieved histomorphological remission after treatment. At present, PCR and flow cytometry are mostly used for clinical detection. [0003] Acute myeloid leukemia (AML) is the largest type of adult leukemia, accounting for about 50%-70%, and is an important fatal disease. In recent years, with the continuous improvement of treatment methods, the proportion of patients with morphological remission is increasing, but most patients still relapse after remission. Knowing the presence or absence of tumor cells in patients who achieve microscopic morphologic remission, and thus the need for further treatment, is a critical step in preventing relapse. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886C12N1/11
CPCC12Q1/6886C12Q2600/118C12Q2600/156C12Q2600/166
Inventor王阳刘进马冉冉崔欢喜任用
OwnerNANJING SIMCERE MEDICAL LAB CO LTD